Q4 2020 13F Holders as of 31 Dec 2020
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share (the "Shares")
-
Shares outstanding
-
274,051,471
-
Number of holders
-
338
-
Total 13F shares, excl. options
-
258,651,597
-
Shares change
-
+4,980,981
-
Total reported value, excl. options
-
$5,190,591,025
-
Value change
-
+$75,448,776
-
Put/Call ratio
-
191%
-
Number of buys
-
162
-
Number of sells
-
-171
-
Price
-
$20.07
Significant Holders of EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) as of Q4 2020
420 filings reported holding EXEL - EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") as of Q4 2020.
EXELIXIS, INC. - Common Stock, par value $0.001 per share (the "Shares") (EXEL) has 338 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 258,651,597 shares
of 274,051,471 outstanding shares and own 94% of the company stock.
Largest 10 shareholders include BlackRock Inc. (31,387,574 shares), VANGUARD GROUP INC (28,470,067 shares), RENAISSANCE TECHNOLOGIES LLC (21,682,651 shares), PRICE T ROWE ASSOCIATES INC /MD/ (17,588,494 shares), FMR LLC (12,750,071 shares), Meditor Group Ltd (12,610,540 shares), JPMORGAN CHASE & CO (11,662,209 shares), FARALLON CAPITAL MANAGEMENT LLC (11,000,000 shares), STATE STREET CORP (10,227,119 shares), and PICTET ASSET MANAGEMENT LTD (6,334,637 shares).
This table shows the top 338 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.